Editorial Policies

  1. 1.- Peer Review Policy
    1. Step 1: Manuscript Submission
    2. Step 2: Editorial Review
    3. Step 3: Scientific Review Committee
    4. Step 4: External Peer Review Process
  2. 2.- Plagiarism and Use of Artificial Intelligence
    1. Artificial Intelligence (AI): Principles and Scope of Use
    2. Acceptable and Unacceptable Uses of AI
    3. Disclosure of AI Use by Authors
    4. Policy Review and Enforcement
  3. 3.- Authorship and Contributions
  4. 4.- Gender Equality
  5. 5.- Code of Ethics
  6. 6.- Open Access
  7. 7.- Copyright
  8. 8.- Open Science
  9. 9.- Privacy

 

1.- Peer Review Policy

Step 1: Manuscript Submission

The submission and receipt of manuscripts for evaluation will be conducted through the RIIAD OJS platform, available at: https://riiad.org/index.php/riiad/user/register?source=%2Findex.php%2Friiad%2Fsubmission%2Fwizard.

Step 2: Editorial Review

The editorial review consists of an initial assessment of manuscripts according to international scientific publishing standards. This includes verification of scope, objectives, and compliance with RIIAD guidelines; confirmation of anonymization (double‑blind peer review); and evaluation of ethical and transparency principles (COPE).

Step 3: Scientific Review Committee

The internal scientific review is conducted by the Scientific Review Committee, composed of researchers affiliated with Centros de Integración Juvenil. This evaluation assesses relevance, originality, methodological quality, adherence to scientific publishing standards (CONSORT, STROBE, PRISMA, etc.), internal consistency, and compliance with ethical research practices involving humans or animals (if applicable). The purpose is to determine whether the manuscript should be forwarded for external peer review.

Step 4: External Peer Review Process

RIIAD submits manuscripts to external peer reviewers. This process is carried out by independent experts under a double‑blind review model to ensure scientific quality, validity, originality, and relevance.

 

2.- Plagiarism and Use of Artificial Intelligence

To guarantee originality, integrity, and transparency, all submitted manuscripts undergo similarity checks using iThenticate®.

The maximum similarity index permitted is 20%. Manuscripts exceeding this threshold will be returned to the author with the similarity report.

If resubmitted and the threshold is again exceeded, the manuscript will be definitively rejected and deemed ineligible for publication.

Artificial Intelligence (AI): Principles and Scope of Use

RIIAD aligns its AI policy with the latest guidelines issued by the Committee on Publication Ethics (COPE).

AI tools (including large language models and generative AI systems) cannot be listed as authors, as they do not meet authorship criteria nor assume responsibility for accuracy, integrity, or originality.

Authors retain full responsibility for all aspects of the work, including data accuracy, interpretation, originality, and ethical compliance.

AI tools cannot independently manage conflicts of interest, copyright, intellectual property, or ethical decision‑making.

Acceptable and Unacceptable Uses of AI

Language correction, grammar review, readability improvement, or formatting support—provided such use is transparent and properly declared.

Unacceptable uses of AI:

  • Generating or fabricating data, results, or references
  • Manipulating images, figures, or data in a misleading manner
  • Replacing substantive human intellectual contributions (study design, data interpretation, scientific judgment).

Disclosure of AI Use by Authors

Authors must explicitly disclose any use of AI tools, specifying the tool/service, purpose, and manuscript sections where applied.

The following statement must be included when applicable:

“Declaration: During the preparation of this document, the authors used the following tool [Name of Tool/Service] for [Purpose]. After using this tool or service, the authors edited and reviewed the generated content. The authors assume full responsibility for the manuscript’s content.”

Failure to comply may result in editorial actions, including rejection, retraction, or restrictions on future submissions.

Policy Review and Enforcement

This policy will be reviewed and updated periodically to reflect technological developments and evolving international standards regarding the ethical use of AI in scientific publishing.

Non-compliance with this policy may result in editorial actions, including manuscript rejection, withdrawal of published articles, or restrictions on future submissions to RIIAD.

 

3.- Authorship and Contributions

To ensure transparency and editorial quality, RIIAD requires authors to specify the order of authorship and detail individual contributions. Authors are encouraged to follow the CRediT taxonomy for role assignment: https://www.elsevier.com/researcher/author/policies-and-guidelines/credit-author-statement.

 

4.- Gender Equality

RIIAD is committed to promoting gender equality, eliminating discrimination, and fostering inclusion in scientific communication, in line with COPE ethical principles. Authors are encouraged to use gender‑inclusive language. Guidance is available at the United Nations resource: Gender‑inclusive language: https://www.un.org/es/gender-inclusive-language/

 

5.- Code of Ethics

RIIAD adheres to the COPE Code of Ethics for all stakeholders (editors, editorial board, authors, reviewers): https://publicationethics.org/. It also complies with the guidelines of the International Committee of Medical Journal Editors (ICMJE): https://www.icmje.org/.

 

6.- Open Access

RIIAD is an open‑access journal. All articles are freely available immediately upon publication under the Creative Commons Attribution–NonCommercial International License (CC BY‑NC 4.0). No submission or processing fees are charged to authors. The journal operates under the principle that providing free access to research fosters greater global knowledge exchange.

 

7.- Copyright

Authors retain copyright and grant RIIAD the right of first publication. Works are simultaneously subject to the CC BY‑NC license, allowing third parties to share the work with proper attribution. Authors may enter into non‑exclusive distribution agreements (e.g., institutional repositories, monographs) provided the initial publication in RIIAD is acknowledged.

Self‑archiving of post‑prints (final publisher PDF) is permitted for non‑commercial purposes in:

  • Social networks
  • Institutional/public repositories
  • Scientific social networks
  • Personal/institutional websites or blogs
  • Google Scholar, ORCID, ResearchID, etc.

 

8.- Open Science

RIIAD endorses Open Science principles, promoting transparency, collaboration, and knowledge reuse.

All texts are distributed under CC BY‑NC 4.0.

Authors are encouraged to deposit research data according to FAIR principles (Findable, Accessible, Interoperable, Reusable): https://www.go-fair.org/fair-principles/.

Persistent identifiers (DOI) are assigned to all articles. Crossmark is used to inform readers of updates or modifications, ensuring record integrity:  https://www.crossref.org/services/crossmark/.

Articles are archived via LOCKSS for digital preservation: https://www.lockss.org/.

 

9.- Privacy

In compliance with the Federal Law on Transparency and Access to Public Information (Mexico), RIIAD declares the following:

  1. Data collected via contact forms will only be used to communicate with authors regarding their submissions.
  2. Data will not be publicized, distributed, or commercialized.
  3. Authors may request deletion of their data at any time by emailing edit.riiad@cij.gob.mx or writing to the journal’s office.
  4. Personal data may be shared with third parties in accordance with Article 22 of the law.

Contact:

Revista Internacional de Investigación en Adicciones. Avenida San Jerónimo #372, Colonia Jardines del Pedregal, Alcaldía Álvaro Obregón, C.P. 01900, Ciudad de México, México.